Duphill AM 400mg/30mg Tablet SR

Introduction

Duphill AM is a prescription medication that contains the active ingredients Doxofylline and Ambroxol. It is commonly used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. Duphill AM helps to open up the airways and improve breathing.

Uses

Duphill AM is primarily prescribed for the management of respiratory conditions. It is used to relieve symptoms such as coughing, wheezing, and shortness of breath associated with asthma, COPD, and bronchitis. This medication helps to reduce inflammation and improve lung function, allowing for easier breathing.

Dosage and Administration

The dosage of Duphill AM may vary depending on the individual’s age, weight, and the severity of their respiratory condition. Follow the instructions provided by your healthcare professional. Typically, the recommended dose for adults is one tablet taken orally once or twice daily, with or without food. The tablet should be swallowed whole and should not be crushed or chewed.

Mechanism of Action

Doxofylline, one of the active ingredients in Duphill AM, belongs to a class of medications known as bronchodilators. It works by relaxing the muscles in the airways, which helps to open them up and improve airflow. Ambroxol, the other active ingredient, is an expectorant that helps to thin and loosen mucus in the airways, making it easier to cough up.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, headache, and dizziness. These side effects are usually mild and temporary. However, if you experience any severe or persistent side effects, such as chest pain, rapid heartbeat, or difficulty breathing, seek medical attention immediately.

Drug Interactions

Duphill AM may interact with certain medications, including theophylline, ciprofloxacin, and fluvoxamine. These interactions can affect the effectiveness and safety of both medications. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements, to avoid potential drug interactions.

Precautions

Before using Duphill AM, inform your healthcare professional about any pre-existing medical conditions, such as heart disease, liver or kidney problems, or a history of seizures. This medication may not be suitable for everyone, and your healthcare professional will determine if it is safe for you to use. Additionally, Duphill AM may interact with certain substances, such as alcohol, so avoid alcohol consumption while taking this medication.

Storage

Duphill AM should be stored at room temperature, away from moisture and heat. Keep this medication out of reach of children and pets. Do not use Duphill AM if it has expired or if the packaging is damaged.

Patient Tips

• Take Duphill AM exactly as prescribed by your healthcare professional.
• Do not change the dosage or stop taking the medication without consulting your healthcare professional.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you have any questions or concerns about Duphill AM, speak to your healthcare professional for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Ambroxol (Drugs.com) [Accessed 30 Jun. 2024] (online) Available at:
• Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1119-29. doi: 10.1517/17425255.4.8.1119. [Accessed 27 Jun. 2024] Available at:
• Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH. Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3. [Accessed 14 Jun. 2024] Available at:
• Weiser T. Ambroxol: a CNS drug? CNS Neurosci Ther. 2008 Spring;14(1):17-24. doi: 10.1111/j.1527-3458.2007.00032.x. [Accessed 19 Jun. 2024] Available at: